MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways (2021)
- Authors:
- USP affiliated authors: VERONEZ, LUCIANA CHAIN - FMRP ; QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; TONE, LUIZ GONZAGA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; SILVA, KETERYNE RODRIGUES DA - FCFRP ; NAGANO, LUÍS FERNANDO PEINADO - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1002/jcb.30153
- Subjects: NEOPLASIAS; CARCINOMA; CÓRTEX ADRENAL; BIOMARCADORES; REGULAÇÃO NEOPLÁSICA DA EXPRESSÃO GÊNICA; ESTEROIDES
- Keywords: MSI2 expression; Adrenocortical carcinoma; Immune infiltration; Prognosis; Steroid biosynthesis
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Cellular Biochemistry
- ISSN: 0730-2312
- Volume/Número/Paginação/Ano: v. 122, n. 12, p. 1925-1935, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VERONEZ, Luciana Chain et al. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, v. 122, n. 12, p. 1925-1935, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcb.30153. Acesso em: 11 fev. 2026. -
APA
Veronez, L. C., Chagas, P. F. das, Correa, C. A. P., Baroni, M., Silva, K. R. da, Nagano, L. F. P., et al. (2021). MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, 122( 12), 1925-1935. doi:10.1002/jcb.30153 -
NLM
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1002/jcb.30153 -
Vancouver
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1002/jcb.30153 - Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia
- Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibiblity to acute lymphoblastic leukemia in Brazilian children
- Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients
- Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a brasilian population
- Study adrenocortical tumors in children and adolescent by technique comparative genomic hybridization (CGH)
- Role of SHOC2 gene in the chemotherapy sensibility process in childhood acute lymphoblastic leukemia
- HDAC9 over-expression correlated with adverse prognosis in acute lymphoblastic leukemia
- A simplified PCR approach for minimal residual disease (MDR) detection at early treatment points stratifies children with acute lymphoblastic leukemia (ALL) into good and poor outcome groups
- mRNA expression of NMP2 and MMP9 and TIMP1 and TIMP2 in childhood all: potential role of TIMP1 as an adverse prognostic factor
- Expression profile of a apoptosis-related genes by real-time quantitative PCR in children with acute lymphoblastic leukemia
Informações sobre o DOI: 10.1002/jcb.30153 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003207766.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
